Home > Animal Health & Nutrition > Veterinary Services > Aquaculture Healthcare Market

Aquaculture Healthcare Market Share

Report ID: GMI4536
Published Date: Dec 2022
Report Format: PDF

Download Free Sample

Aquaculture Healthcare Market Share

Enterprises involved in the aquaculture healthcare market include :

Virbac
Zeal Aqua
Phibro Animal Health Corporation
Benchmark PLC
Ceva Sante
Archer Daniels Midland Company
Elanco
Merck
Zoetis LLC

These companies are focused on reaching untapped markets to increase sales. For instance, in September 2020, Virbac, an animal health pharmaceutical firm, acquired a variety of tilapia vaccines from Ictyogroup, an animal health company specializing in R&D biology, and also signed a deal with Ictyogroup for the development of additional tilapia vaccines for the Aqua Virbac division.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for aquaculture healthcare was valued at more than USD 900 million in 2022 and is poised to grow at over 8.5% CAGR through 2032 owing to the burgeoning demand for fish protein worldwide.

Retail/aqua stores segment is anticipated to generate USD 460 million in revenue by 2032 due to the increasing availability of innovative therapeutic treatments at retail stores.

Asia Pacific aquaculture healthcare market is expected to expand at more than 9.5% CAGR over the projected period owing to the rising demand for crustacean therapeutic goods throughout the region.

Leading industry participants involved in the aquaculture healthcare industry are Virbac, Zeal Aqua, Phibro Animal Health Corporation, Benchmark PLC, Ceva Sante, Archer Daniels Midland Company, Elanco, Merck, Zoetis LLC, and others